The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:

General Notices

• Frequently Asked Questions for NOT-AG-20-022 Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
  National Institute on Aging

• Pre-Application Webinar for RFA-CA-20-031, Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)
  National Cancer Institute

Notice of Changes to Funding Opportunities

• Notice of Eligibility Change for NIDCD Urgent Competitive Revisions and Administrative Supplements for Research on COVID-19
  National Institute on Deafness and Other Communication Disorders

• Notice of Change to Key Dates for PAR-19-211 "NINDS Institutional Research Training Program (T32)"
  National Institute of Neurological Disorders and Stroke

• Notice of Change to Key Dates for PAR-19-228 "Institutional Translational Research Training Program (T32)"
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging

• Notice of Change to Key Dates for PAR-20-076 "Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed)"
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute of General Medical Sciences
  National Institute of Mental Health

• Notice of NCATS Withdrawal from Participation in PAR-18-690, Innovative Therapies and Tools for Screenable Disorders in Newborns (R03 Clinical Trial Optional)
  National Center for Advancing Translational Sciences

• Notice of NCATS Withdrawal from Participation in PAR-18-689, Innovative Therapies and Tools for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
  National Center for Advancing Translational Sciences

Notices of Special Interest

• Notice of Special Interest (NOSI): Cannabis, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults
  National Institute on Drug Abuse

• Notice of Special Interest (NOSI): Availability of Administrative Supplements to Diversify the NIDDK Clinical Trial Workforce
  National Institute of Diabetes and Digestive and Kidney Diseases

• Notice of Special Interest (NOSI): Availability of Administrative Supplements to NIDDK STEP-UP Centers for Increased Outreach
  National Institute of Diabetes and Digestive and Kidney Diseases

• Notice of Special Interest: Administrative Supplements for Research on Ethical, Legal and Social Issues regarding Post-mortem Pediatric Tissue Procurement for Research Purposes (Admin Supp Clinical Trial Optional)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute

• HEAL Initiative: Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements to Support Strategies to Reduce Stigma in Pain Management and Opioid Use Disorder (OUD) and Treatment
  Office of Behavioral and Social Sciences Research
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Neurological Disorders and Stroke
  Office of Disease Prevention
  Office of Research on Women's Health

• Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs
  National Center for Advancing Translational Sciences

Funding Opportunities

• Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
  National Institutes of Health
  John E. Fogarty International Center
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
   
• Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)
• Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed)
• Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required)
  National Institutes of Health
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Neurological Disorders and Stroke
   
• Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Institute on Aging
  National Institute on Drug Abuse
   
• Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed).
  National Institute of Allergy and Infectious Diseases
   
• Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
  Office of Strategic Coordination (Common Fund)
   

Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu  or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu  or Dave Myers at dave-myers@uiowa.edu  or Lynn Hudachek at lynn-hudachek @uiowa.edu